Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab

Although nivolumab, a programmed cell death 1 (PD‐1) inhibitor, is a standard therapy for platinum‐refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), no definitive biomarkers have been reported thus far. This study aimed to select promising prognostic markers in ni...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Sci
Main Authors: Nishikawa, Daisuke, Suzuki, Hidenori, Beppu, Shintaro, Terada, Hoshino, Sawabe, Michi, Kadowaki, Shigenori, Sone, Michihiko, Hanai, Nobuhiro
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780035/
https://ncbi.nlm.nih.gov/pubmed/33078505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14706
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki